Medicalgorithmics Expands Globally, Forges New US Partnerships, and Boosts Q4 2023 Revenue
Implementing its ongoing strategy, Medicalgorithmics, a medtech company listed on the sWIG80 index, has successfully added nine new clients, including five Independent Diagnostic Testing Facility (IDTF) centers in the USA. The company has completed a contract and started a collaboration with First-Call Medical, marking its fifth new IDTF partner in the USA, specializing in heart disease diagnostics. Using Medicalgorithmics’ AI-powered diagnostic platform, the new partner will analyze EKG signals of patients for arrhythmia and other disorders.